亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety

加巴喷丁 普瑞巴林 神经病理性疼痛 医学 荟萃分析 系统回顾 麻醉 梅德林 替代医学 内科学 病理 政治学 法学
作者
Victor Mayoral,Rafael Gálvez,Marta Ferrándiz,Xoán Miguéns Vázquez,Carlos Cordero García,Antonio Alcántara Montero,Concepción Pérez,María Pérez‐Páramo
出处
期刊:Frontiers in pain research [Frontiers Media]
卷期号:5: 1513597-1513597 被引量:49
标识
DOI:10.3389/fpain.2024.1513597
摘要

Introduction: Neuropathic pain is a prevalent and burdensome condition, and both pregabalin and gabapentin are widely used for its treatment. However, there is a lack of clarity regarding their comparative efficacy and safety. This meta-analysis aims to evaluate and compare the effectiveness and safety of pregabalin vs. gabapentin in managing neuropathic pain. Methods: This study followed PRISMA guidelines and employed the PICOS search strategy. Comparative studies (clinical trials and cohort studies) were included, with patients with neuropathic pain treated either with pregabalin or gabapentin. Primary outcomes assessed were efficacy and safety. Data were extracted from PubMed, Embase, Scopus, and the Cochrane Collaboration Library databases. The risk of bias was evaluated using the Cochrane Review Manager tool. Statistical analysis was performed using Review Manager 5.4.1 software, calculating effect sizes and conducting sensitivity analysis based on medication dosage. Results: A total of 14 studies with 3,346 patients were analyzed. Pregabalin showed superior results compared to gabapentin in the Visual Analog Scale (VAS) at various time intervals up to 12-14 weeks (SMD -0.47, 95% CI -0.74 to -0.19). The pregabalin group also had significant improvements in SF-12/SF-36/EQ-5D scores (SMD 0.39, 95% CI 0.11-0.68) and experienced more days with no/mild pain (MD 9.00, 95% CI 8.93-9.07) and fewer days with severe pain (MD -3.00, 95% CI -4.96 to -1.04). Pregabalin resulted in lower opioid consumption (OR 0.50, 95% CI 0.33-0.76). Gabapentin had a higher incidence of nausea and vomiting. Sensitivity analysis supported the efficacy of pregabalin. Conclusion: In conclusion, pregabalin demonstrated superior and faster efficacy in alleviating neuropathic pain than gabapentin did. Additionally, it improved patient-reported outcomes, resulted in lower opioid consumption, and led to fewer adverse events. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=565208, PROSPERO (CRD42024565208).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
冷酷冬卉完成签到,获得积分10
1秒前
7秒前
24秒前
moiaoh完成签到,获得积分10
26秒前
开心兔子完成签到 ,获得积分10
27秒前
28秒前
moiaoh发布了新的文献求助100
29秒前
c_phoebe发布了新的文献求助10
30秒前
酷炫绮琴完成签到,获得积分10
35秒前
42秒前
45秒前
大气钥匙完成签到,获得积分10
46秒前
怡然的飞珍完成签到,获得积分10
48秒前
123123完成签到,获得积分10
49秒前
研友_VZG7GZ的应助被佳莉采纳,获得10
59秒前
c_phoebe完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
懵懂的念波完成签到,获得积分10
1分钟前
1分钟前
痴情的归尘完成签到,获得积分10
1分钟前
1分钟前
1分钟前
桐桐的应助被南宫雪采纳,获得10
1分钟前
zzz完成签到,获得积分10
1分钟前
科目三的应助被科研通管家采纳,获得10
1分钟前
1分钟前
充电宝的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
Orange的应助被科研通管家采纳,获得10
1分钟前
英俊的铭的应助被科研通管家采纳,获得10
1分钟前
1分钟前
忧郁思远完成签到,获得积分10
1分钟前
1分钟前
teyr完成签到,获得积分10
2分钟前
机灵的夜梅完成签到,获得积分10
2分钟前
Pikachu完成签到,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158694
求助须知:如何正确求助?哪些是违规求助? 9554462
关于积分的说明 21719198
捐赠科研通 7748257
什么是DOI,文献DOI怎么找? 3427070
关于科研通互助平台的介绍 2551949
邀请新用户注册赠送积分活动 2471308